DEFICIENT, HLA-RESTRICTED, CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC T-CELLS AND NATURAL-KILLER CELLS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME

被引：28

作者：

ROOK, AH

MANISCHEWITZ, JF

FREDERICK, WR

EPSTEIN, JS

JACKSON, L

GELMANN, E

STEIS, R

MASUR, H

QUINNAN, GV

机构：

[1] US FDA,CTR DRUGS & BIOL,OFF BIOL RES & REVIEW,DIV VIROL,BETHESDA,MD 20014

[2] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20205

[3] NIH,CTR CLIN,DEPT CRIT CARE MED,BETHESDA,MD 20205

来源：

JOURNAL OF INFECTIOUS DISEASES | 1985年 / 152卷 / 03期

关键词：

D O I：

10.1093/infdis/152.3.627

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：627 / 630

页数：4

共 13 条

[1] CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXICITY MEDIATED BY LYMPHOCYTES-NON-T FROM PERIPHERAL-BLOOD OF NORMAL VOLUNTEERS [J].

KIRMANI, N ;

GINN, RK ;

MITTAL, KK ;

MANISCHEWITZ, JF ;

QUINNAN, GV .

INFECTION AND IMMUNITY, 1981, 34 (02) :441-447

[2] IMPAIRED PRODUCTION OF LYMPHOKINES AND IMMUNE (GAMMA) INTERFERON IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].

MURRAY, HW ;

RUBIN, BY ;

MASUR, H ;

ROBERTS, RB .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (14) :883-889

[3] HERPESVIRUS INFECTIONS IN THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].

QUINNAN, GV ;

MASUR, H ;

ROOK, AH ;

ARMSTRONG, G ;

FREDERICK, WR ;

EPSTEIN, J ;

MANISCHEWITZ, JF ;

MACHER, AM ;

JACKSON, L ;

AMES, J ;

SMITH, HA ;

PARKER, M ;

PEARSON, GR ;

PARRILLO, J ;

MITCHELL, C ;

STRAUS, SE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (01) :72-77

[4] COMPARATIVE VIRULENCE AND IMMUNOGENICITY OF THE TOWNE STRAIN AND A NONATTENUATED STRAIN OF CYTOMEGALOVIRUS [J].

QUINNAN, GV ;

DELERY, M ;

ROOK, AH ;

FREDERICK, WR ;

EPSTEIN, JS ;

MANISCHEWITZ, JF ;

JACKSON, L ;

RAMSEY, KM ;

MITTAL, K ;

PLOTKIN, SA ;

HILLEMAN, MR .

ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :478-483

[5]

QUINNAN GV, 1984, REV INFECT DIS, V6, P156

[6] CYTO-TOXIC T-CELLS IN CYTOMEGALOVIRUS-INFECTION - HLA-RESTRICTED LYMPHOCYTE-T AND NON-T-LYMPHOCYTE CYTO-TOXIC RESPONSES CORRELATE WITH RECOVERY FROM CYTOMEGALOVIRUS-INFECTION IN BONE-MARROW-TRANSPLANT RECIPIENTS [J].

QUINNAN, GV ;

KIRMANI, N ;

ROOK, AH ;

MANISCHEWITZ, JF ;

JACKSON, L ;

MORESCHI, G ;

SANTOS, GW ;

SARAL, R ;

BURNS, WH .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (01) :7-13

[7]

QUINNAN GV, 1981, J IMMUNOL, V126, P2036

[8] IMPORTANCE OF CYTO-TOXIC LYMPHOCYTES DURING CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS [J].

ROOK, AH ;

QUINNAN, GV ;

FREDERICK, WJR ;

MANISCHEWITZ, JF ;

KIRMANI, N ;

DANTZLER, T ;

LEE, BB ;

CURRIER, CB .

AMERICAN JOURNAL OF MEDICINE, 1984, 76 (03) :385-392

[9] INTERLEUKIN-2 ENHANCES THE DEPRESSED NATURAL-KILLER AND CYTOMEGALOVIRUS-SPECIFIC CYTO-TOXIC ACTIVITIES OF LYMPHOCYTES FROM PATIENTS WITH THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].

ROOK, AH ;

MASUR, H ;

LANE, HC ;

FREDERICK, W ;

KASAHARA, T ;

MACHER, AM ;

DJEU, JY ;

MANISCHEWITZ, JF ;

JACKSON, L ;

FAUCI, AS ;

QUINNAN, GV .

JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (01) :398-403

[10]

SIEGEL JP, 1985, J CLIN INVEST

← 1 2 →